MedPath

To see the effect of guduchi siddhaksheer ghrut in management of lumbar spondylosis when administered through rectal route.

Phase 4
Not yet recruiting
Conditions
Osteoarthritis. Ayurveda Condition: SANDHIGATAVATAH,
Registration Number
CTRI/2025/05/086448
Lead Sponsor
Dr. Pratiksha Jaishankar Tripathi
Brief Summary

Nowadays humans are suffering from many lifestyle-related disorders due to the adaption of modern

lifestyle. Katisandhigata vata is one of them. It is not only clinical but also social, economic & public health

problems affecting the general population indiscriminately. It is not a life-threatening condition, but it

causes great discomfort and restriction in social and other activities [3]. 25% of females are prone to

Sandhigata Vata where whereas 16% of males are affected due to it. Conventional treatments, including

pharmacological interventions and physical therapy, often provide limited relief and may be associated with

side effects. Guduchi siddhaksheer ghrut basti, an ayurvedic therapeutic procedure involves the

administration of medicated Ksheerbasti prepared with guduchi. This study aims to evaluate the

effectiveness of guduchi siddhaksheer ghrut basti in managing symptoms of lumbar spondylosis, potentially

offering a holistic and safer alternative to conventional treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Patients having classical signs and symptoms of Katisandhigata Vata.
  • (Niraam avastha) a.
  • Katishoola (pain in low back) b.
  • Katistambha (stiffness of lower back) c.
  • Akunchana Prasarana Pravrutti Savedana (painful joint movements) Patients aged between 18 and 60 years and all genders.
  • Diagnosed with lumbar spondylosis based on clinical and radiological finding.
  • Willingness to participate and provide informed consent.
Exclusion Criteria
  • Patients with acute lumbar spine injuries or fractures.
  • Presence of systemic diseases such as diabetes, rheumatoid arthritis, CA, or any major autoimmune disorder Pregnant or lactating women.
  • Patients not willing to consent.
  • Patient not eligible for basti karma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Katishoola14 days
Secondary Outcome Measures
NameTimeMethod
KatistambhaAkunchana Prasarana Pravrutti Savedana

Trial Locations

Locations (1)

APMs Ayurved mahavidyala and seth R.V ayurved hospital sion

🇮🇳

Mumbai, MAHARASHTRA, India

APMs Ayurved mahavidyala and seth R.V ayurved hospital sion
🇮🇳Mumbai, MAHARASHTRA, India
Dr Pratiksha Jaishankar Tripathi
Principal investigator
8355803632
drpratiksha.tripathi99@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.